Skip to content
Voyager Therapeutics Inc icon

Voyager Therapeutics Inc

VYGRStocksBiotechnologyUnited StatesNasdaqUSD

Price

$1.53

Today

-5.0%

YTD

-63.9%

About

Voyager Therapeutics Inc is a US-based clinical-stage biotechnology company focused on developing gene therapies for severe neurological diseases. Its primary aim is to create transformative treatments for patients with central nervous system disorders. Operating within the biotechnology sector, Voyager Therapeutics Inc uses adeno-associated virus (AAV) gene therapy technology to target the root causes of neurological conditions. The company’s global research initiatives strive to deliver long-lasting therapeutic benefits for conditions like Parkinson’s and ALS. Explore VYGR share prices and other stocks on eToro. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

Price chart
Closing price history for VYGR (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-0.88
P/S (TTM)3.77
P/B (TTM)0.70
Market cap$95.21M
Cap tierMicro-cap
Industry avg P/E-5.31

Profitability

Gross margin85.16%
EBIT margin-450.12%
Net margin-615.20%
ROE-58.90%
ROA-44.92%

Earnings & Revenue

Revenue (TTM)$25.11M
Revenue growth (1Y)-19.8%
EPS (TTM)-$1.74
Free cash flow$-109.83M
Total debt$30.51M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.51
Employees141
Next earnings9 Mar '27
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.